Physicians who also conduct research play a crucial role: They translate the latest research findings into everyday clinical practice and incorporate questions arising from clinical care into research projects.
Diabetology and endocrinology are constantly evolving: New findings on diabetes subtypes, individual courses of disease, and modern treatment approaches are paving the way for increasingly personalized care. Physicians who also conduct research (clinician scientists) play a crucial role in addressing this complexity: They translate the latest research findings into everyday clinical practice and, conversely, incorporate questions arising from clinical care into research projects.
With ENDODIATRACK, the DDZ in Düsseldorf is establishing a unique training opportunity that brings together clinical diabetology, endocrinology, and metabolic medicine. “The program helps train the next generation of clinician scientists in diabetology, endocrinology, and internal medicine and sustainably strengthen the bridge between research and the care of people with diabetes. In doing so, it contributes to the continued advancement of evidence-based, forward-looking medicine,” says Professor Michael Roden, Scientific Director and Spokesperson of the Board of the DDZ as well as Director of the Department of Endocrinology and Diabetology at the University Hospital Düsseldorf (UKD).
ENDODIATRACK combines structured clinical training with protected research time
Participants develop an independent scientific profile in the fields of diabetology, endocrinology, and internal medicine. A structured curriculum, individualized mentoring programs, and active participation in clinical and research projects lay the foundation for a long-term career as a clinical academic. In addition to conducting and coordinating clinical trials at the DDZ, particular emphasis is placed on understanding hormonal and metabolic disorders and their interactions throughout the course of disease.
ENDODIATRACK at a Glance
- What: Clinician scientist program in diabetology, endocrinology, and internal medicine
- For whom: Physicians who have completed their medical degree, are licensed to practice medicine, and wish to combine structured clinical training with protected research time
- Where: German Diabetes Center (DZD), Düsseldorf
- Areas of focus: Clinical research, hormonal and metabolic disorders, innovative diagnostics, translational research
- More about ENDODIATRACK: ENDODIATRACK
Requirements and Application Process
To apply, you must have completed a medical degree, hold a license to practice medicine in Germany, and have a strong interest in clinical metabolic research, working with study participants, and caring for people with diabetes. Applicants should also be committed, work well in a team, be enthusiastic about clinical research, and have good English language skills.
Contact for Inquiries
If you are interested, please contact Dr. Kálmán Bódis, senior physician and mentor at ENDODIATRACK: kalman.bodis@ddz.de
Media contact:
German Diabetes Center (DDZ)
Press office
Susan Jörges
Auf‘m Hennekamp 65
40225 Düsseldorf
Phone: +49 (0)211 3382-450
pressestelle@ddz.de
The German Diabetes Center (DDZ) serves as the German reference center for diabetes. Its objective is to contribute to the improvement of prevention, early detection, diagnosis and treatment of diabetes mellitus. At the same time, the research center aims at improving the epidemiological data situation in Germany. The DDZ coordinates the multicenter German Diabetes Study and is a point of contact for all players in the health sector. In addition, it prepares scientific information on diabetes mellitus and makes it available to the public. The DDZ is part of the Leibniz Association (Wissenschaftsgemeinschaft Gottfried Wilhelm Leibniz, WGL) and is a partner of the German Center for Diabetes Research (DZD e.V.). www.ddz.de/en
The German Center for Diabetes Research (DZD) is a national association that brings together experts in the field of diabetes research and combines basic research, translational research, epidemiology and clinical applications. The aim is to develop novel strategies for personalized prevention and treatment of diabetes. Members are Helmholtz Munich – German Research Center for Environmental Health, the German Diabetes Center in Düsseldorf, the German Institute of Human Nutrition in Potsdam-Rehbrücke, the Paul Langerhans Institute Dresden of Helmholtz Munich at the University Medical Center Carl Gustav Carus of the TU Dresden and the Institute for Diabetes Research and Metabolic Diseases of Helmholtz Munich at the Eberhard-Karls-University of Tuebingen together with associated partners at the Universities in Heidelberg, Cologne, Leipzig, Lübeck and Munich. www.dzd-ev.de/en
